Bioelectronica® Corporation Wins 2021 CYTO Virtual Interactive Annual Innovation Showcase

RENO, Nev., June 18, 2021 /PRNewswire/ — Bioelectronics® Corporation (“Bioelectronica”) today announced that the company has won the Innovation Showcase competition held at CYTO Virtual Interactive 2021. ISAC, the International Society for the Advancement of Cytometry, held its meeting annual CYTO June 7-10, 2021.

dr. Amar BasuPhD, Scientific Advisor at Bioelectronica, presented a high-level overview of the company Hypercell® platform to the jury. Hypercell® is a next-generation platform that uses patent-pending electrofluidic hardware, reagents, and data science to accelerate biopharmaceutical discovery and production workflows. The system detects and sorts individual cells using proprietary reagent sets and computer vision algorithms. Hypercell® is a platform for research use only and is not intended to diagnose, treat or cure any disease. Bioelectronica has won numerous awards and accolades for its innovative platform, including the New Product Award at SLAS 2020.

Bioelectronica was one of three finalists to qualify for judging. Session moderators were Guillaume HyunPhD, Venture Partner at Genoa Ventures, and Elena HoldenMD, President and CEO of Tomocube United StatesInc. The distinguished jury included Alexis JiPhD, Partner at Illumina Ventures, Dara WrightVice President and President of the Clinical Diagnostics Group at Bio-Rad Laboratories, and Christian dosagePhD, head of chemical biology research and development department at Miltenyi Biotec.

Jonathan HullPhD, co-founder and CEO, said, “We are honored to have been part of this showcase of innovation among reputable peers and are thrilled to see that Hypercell® continues to receive prestigious accolades. Our Hypercell® is the first system to use computer vision to sort individual cells based on their secreted biomarkers, enabling high-throughput, high-viability functional assays.

For more information on Hypercell® platform, please visit our website at

About Bioelectronica

Bioelectronics® is a research-stage biotechnology company that develops smart digital tools for drug discovery, cell screening and sorting. Bioelectronica’s technology platform combines computer vision, biochemical reagents and consumer electronics to accelerate discovery. We believe that by transforming biochemistry through digital innovation, we are fundamentally changing the speed and price of therapeutic discovery and development. For more information on how your workflow can benefit from Bioelectronica’s progressive innovation, contact Jonathan Hull at [email protected]. Bioelectronics® and Hypercellular® are registered trademarks of Bioelectronica. Hypercell® is for research purposes only.

Quote View original content to download multimedia:

SOURCE Bioelectronics

Perry A. Thomasson